Hybio Pharmaceutical Co Ltd SZSE:300199:
SAYS ITS LIRAGLUTIDE INJECTION APPROVED BY CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR TREATING ADULT TYPE 2 DIABETES
Hybio Pharmaceutical's Liraglutide Injection Approved By China's National Medical Products Administration
Earlier from Hybio Pharmaceutical Co., Ltd. Class A
- Hybio's generic weight-loss drug set for FDA review
- Hybio Pharmaceutical Plans To Raise Fund Via Share Private Placement